Preclinical Research

DermTech: demand to strengthen pharma partnerships over next 5 years

DermTech’s patented platform technology support compound advancement through the clinical stages of development.(Image: iStock/Pixtum)

DermTech, Inc. has announced two new collaborations with pharmaceutical companies and expects more to follow as the demand for personalized, precision medicine increases.

Plasticell is collaborating with the University of Edinburgh and Kings College London. (Image: iStock/Sashkinw)

Plasticell secures funding for red blood cell substitute development

(Image: iStock/scyther5)

Partnering key to deliver next-gen drug delivery tech, say industry experts

Inoviem Scientific is a privately-owned contract research biotech (CRB) offering preclinical and clinical services. (Image: iStock/arsenisspyros)

Inoviem Scientific raises €750k, increasing lab space five-fold

Emery Pharma is a contract research organization located in Alameda, CA. (Image: iStock/BrianAJackson)

LiveLeaf contracts Emery Pharma to advance next-gen anti-infective drugs

TransCelerate BioPharma launched in 2012 with the goal of accelerating the research and development of new therapies. (Image: iStock/JK1991)

Cross-industry partnership looks to accelerate drug discovery through data sharing

The new approach allows companies to obtain biowaivers for acyclovir cream without conducting in vivo bioequivalence studies. (Image: iStock/styf22)

Novel in vitro approach bypasses in vivo bioequivalence studies

(Image: Envigo)

Envigo announces new double knockout mouse model

The NCG model was developed using CRISPR gene editing technology. (Image: Charles River Laboratories)

Charles River launches first CRISPR-generated immunodeficient model

WuXi’s LabNetwork integrates with Reaxys chemistry database

WuXi's LabNetwork integrates with Reaxys chemistry database

More Preclinical Research